Vertex Pharmaceuticals
VRTX
VRTX
483 hedge funds and large institutions have $17.4B invested in Vertex Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 172 increasing their positions, 191 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
483
Holders Change
-5
Holders Change %
-1.02%
% of All Funds
12.09%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
61
Increased
172
Reduced
191
Closed
55
Calls
$117M
Puts
$123M
Net Calls
-$5.9M
Net Calls Change
-$13.6M
Top Buyers
| 1 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$146M |
| 2 |
ClearBridge Investments
New York
|
+$99.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$65.3M |
| 4 |
Two Sigma Advisers
New York
|
+$61.5M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$55.3M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$286M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$209M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$120M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$113M |
| 5 |
O
OppenheimerFunds
New York
|
-$75.4M |
